Sophiris Bio Inc. (SHS.TO) Adds Gerald T. Proehl To Its Board Of Directors
3/20/2014 6:41:38 AM
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing a clinical stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH) or enlarged prostate, today announced the appointment of Gerald T. Proehl to its board of directors effective March 19, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by